Goldman adopte une position prudente sur les grandes pharmas, voit un potentiel chez Eli Lilly
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here: